Published in Support Care Cancer on November 18, 2006
A survey on physician knowledge and attitudes towards clinical use of morphine for cancer pain treatment in China. Support Care Cancer (2009) 0.95
Palliative care in enugu, Nigeria: challenges to a new practice. Indian J Palliat Care (2011) 0.93
Opioid-prescribing Practices in Chronic Cancer Pain in a Tertiary Care Pain Clinic. Indian J Palliat Care (2011) 0.91
Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain (2012) 0.90
Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med (2015) 0.81
Knowledge, practices, and perceived barriers regarding cancer pain management among physicians and nurses in Korea: a nationwide multicenter survey. PLoS One (2014) 0.78
Current Clinical Opinions, Attitudes and Awareness of Interns Regarding Post-operative and Cancer Pain Management in A Tertiary Care Centre. Indian J Palliat Care (2015) 0.77
Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study. Yonsei Med J (2012) 0.77
Rationale, design, and implementation protocol of the Dutch clinical practice guideline pain in patients with cancer: a cluster randomised controlled trial with Short Message Service (SMS) and Interactive Voice Response (IVR). Implement Sci (2011) 0.76
Healthcare Providers' Knowledge and Current Practice of Pain Assessment and Management: How Much Progress Have We Made? Pain Res Manag (2016) 0.75
Evaluating resident physicians' knowledge, attitude, and practice regarding the pain control in cancer patients. Iran J Cancer Prev (2015) 0.75
Practices and Attitudes Concerning Endometriosis Among Nurses Specializing in Gynecology. Glob Qual Nurs Res (2016) 0.75
Investigation and analysis of oncologists' knowledge of morphine usage in cancer pain treatment. Onco Targets Ther (2014) 0.75
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med (1993) 3.25
Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain (1995) 2.69
Multicentre study of cancer pain and its treatment in France. BMJ (1995) 1.78
Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology (2004) 1.25
Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage (1990) 1.15
Factors influencing physician management of cancer pain. Cancer (1986) 0.97
Predictors of prescription of morphine for severe cancer pain by physicians in Korea. Ann Oncol (2005) 0.91
Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain (2001) 0.89
Multicenter study of pain and its management in patients with advanced cancer in Korea. J Pain Symptom Manage (2003) 0.87
Barriers to the management of cancer pain. Oncology (Williston Park) (1987) 0.87
Pain and its treatment in patients with cancer in Korea. Oncology (2003) 0.86
Nurses' willingness to maximize opioid analgesia for severe cancer pain, and its predictor. Support Care Cancer (2005) 0.80
The management of pain in the oncology patient. Obstet Gynecol Clin North Am (2001) 0.78
Retracted Reliability and validity of the Korean Cancer Pain Assessment Tool (KCPAT). J Korean Med Sci (2005) 0.75
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain (2004) 4.72
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst (2005) 4.51
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol (2009) 2.75
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol (2011) 2.70
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer (2011) 2.18
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain (2007) 2.07
Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage (2012) 1.97
Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol (2012) 1.90
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain (2008) 1.69
Authors' reply to Tendas et al. J Pain Symptom Manage (2013) 1.66
A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck (2007) 1.63
Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun (2010) 1.58
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage (2002) 1.58
Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol (2006) 1.52
Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain (2006) 1.48
Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage (2003) 1.47
The role of statins in cancer therapy. Oncologist (2006) 1.46
Patient-reported outcomes: instrument development and selection issues. Value Health (2007) 1.46
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer (2002) 1.46
Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer (2008) 1.43
Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage (2003) 1.42
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J (2014) 1.40
Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol (2012) 1.38
Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain (2006) 1.33
Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer (2004) 1.32
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun (2012) 1.31
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30
[Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc) (2003) 1.26
Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25
Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology (2004) 1.25
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain (2004) 1.24
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23
Symptom burden in cancer survivorship. J Cancer Surviv (2007) 1.18
Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage (2005) 1.18
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). J Cancer Res Clin Oncol (2013) 1.18
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17
Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol (2004) 1.15
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood (2013) 1.14
Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.13
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2006) 1.12
Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer (2010) 1.11
Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol (2002) 1.11
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol (2011) 1.11
Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2005) 1.07
Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size. Cancer Res Treat (2010) 1.06
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys (2008) 1.05
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res (2013) 1.04
Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol (2004) 1.03
Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst (2010) 1.03
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer (2010) 1.03
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet (2009) 1.03
Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology (2008) 0.99
Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage (2007) 0.99
Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage (2008) 0.99
Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage (2006) 0.98
Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail (2008) 0.98
Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer (2010) 0.98
Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer (2010) 0.98
People in pain: how do they seek relief? J Pain (2007) 0.98
Assessment of clinical relevant fatigue level in cancer. Support Care Cancer (2007) 0.97
Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys (2009) 0.97
Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage (2007) 0.97
Lessons learned from a multiple-dose post-operative analgesic trial. Pain (2004) 0.97
High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck (2012) 0.96
What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Symptom Manage (2007) 0.96
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol (2013) 0.96
Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol (2002) 0.95
Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci (2007) 0.95
Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations. Oncologist (2007) 0.95
Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage (2008) 0.94